Marvell tried to ease a big investor concern, but the stock's slump shows that doubts still linger

Marvell Technology's stock fell over 7% despite in-line Q1 results, as investors remain concerned about the company's custom chip programs with Amazon and Microsoft. While CEO Matthew Murphy expressed confidence in the Amazon Trainium3 project and progress on the Microsoft Maia program, analysts suggest investors need more clarity on Marvell's roadmap, particularly regarding potential competition and deployment scale, before becoming more bullish. Upcoming investor event on June 17 is expected to provide further details.

Analysis

Marvell Technology's (MRVL) shares declined over 7% despite reporting in-line fiscal first-quarter results, as investor focus remained squarely on persistent uncertainties surrounding its custom artificial intelligence (AI) chip business with key hyperscale clients, Amazon.com Inc. (AMZN) and Microsoft Corp. (MSFT). CEO Matthew Murphy conveyed confidence, stating that Marvell's custom chip revenue is benefiting from multiple programs, with the Amazon Trainium3 project described as a key driver for which 3-nanometer wafer and advanced packaging capacity have been secured for production starting next year. He also noted positive progress on a custom AI accelerator for another U.S. hyperscaler, understood to be Microsoft's Maia project, with engagement on follow-on generations. However, analysts from Jefferies remarked that this commentary was unlikely to assuage investor concerns, with clarity on Marvell's custom chip roadmap, particularly for its Trainium2 business with Amazon where wider deployments are unconfirmed, anticipated at the June 17 investor event. Further concerns were highlighted by TD Cowen Securities, noting that Murphy's acknowledgement of customers potentially pursuing multiple chip partners could dampen sentiment. BNP Paribas Exane pointed to lingering investor worries about the Microsoft Maia project due to conflicting supply-chain checks. Melius Research characterized MRVL as a "show-me story," citing the lack of data-center upside in Q1 results and current quarter guidance, which intensifies scrutiny on the AI business ramp. The stock's significant year-to-date decline, approaching 50% prior to this earnings report, underscores the market's demand for more definitive evidence of growth and competitive positioning in its AI ventures.

Key Decisions for Investors

• Investors should recognize the heightened uncertainty and "show-me" status of Marvell's stock, with its performance heavily contingent on resolving doubts about its custom AI chip engagements with Amazon and Microsoft.
• The upcoming investor event on June 17 is a critical inflection point; closely monitor for detailed strategic roadmaps, clarification on customer commitment levels, potential exclusivity, and concrete evidence of deployment scale for both the Trainium and Maia chip programs.
• Given the stock's recent underperformance and negative sentiment, assess risk tolerance carefully, as further ambiguity could pressure the shares, while positive, detailed disclosures on June 17 could serve as a significant catalyst.